Navigation Links
Some Immature Brain Cells May Promote Tumors
Date:1/7/2008

But animal studies show cancer gene can be turned on and off

MONDAY, Jan. 7 (HealthDay News) -- Much like a child who becomes a bully while his peers are becoming thoughtful and kind, some immature brain cells go through an alteration in their development that allows them to grow into cancerous tissue, a new study finds.

National Cancer Institute (NCI) researchers have identified a chemical process that turns off the gene that prevents the growth of tumor tissue. The gene can be turned back on and the risk of tumor tissue reduced, said the team, which suggests a potential avenue for future cancer treatment research.

The cells in question are known as tumor-initiating cells with stem-like properties (TICs). These cells are thought to cause the aggressive brain cancer, glioblastoma multiforme, when there is a breakdown in the way in which the cells' genes are expressed. TICs behave like stem cells in many ways, but, instead of growing into healthy tissues, they grow into a tumor. Researchers have reported the presence of TICs in breast, colon, lung and brain cancers.

The NCI team used tumor tissue from people with glioblastoma multiforme to develop a cell that ignored the effects of two proteins -- bone morphogenetic protein-2 (BMP2) and ciliary neurotrophic factor (CNTF) -- that usually cause brain stem cells to grow. Instead, the cells partially responded to one protein (BMP2) and not the other, which the researchers explained as an immature, developing cell response.

When the researchers compared the behavior of the specially grown cells with normal neuronal stem cells, they learned that one of the genes that regulates the response to BMP2 was not working in the new cells. When they turned that gene on, the cells began to respond more normally and were less likely to grow into tumor tissue. Further study revealed that the gene was blocked by a chemical process called methylation, which is thought to be responsible for silencing genes that would otherwise prevent many other cancers.

Methylation, the chemical process that could be behind allowing cancer growth, is also key to the growth of cells in young brains, said the researchers, who found that demethylating the newly created cells caused them to behave more normally and in a similar way to brain cells in embryos, confirming the researchers' suspicion that immature brain cells may be at the root of cancer growth.

The team then analyzed 54 glioblastoma multiforme tumors and found that one in five (20 percent) contained signs of the same difficulty with the BMP2 gene that the researchers saw in the lab. These tumors were also methylated.

"This research highlights an example of a stem cell whose normal development has been blocked in such a way as to prevent it from differentiating as well as to force it to contribute to the development of an aggressive tumor," research leader Dr. Howard Fine, chief of the Neuro-Oncology Branch at the NCI's Center for Cancer Research, said in a prepared statement. "The results we have generated can help us better understand the biology of neuronal stem-like starter cells in glioblastoma multiforme and other cancers, and give us a strong rationale for investigating BMPR1B as a potential target for therapeutic development."

The study was published in the January issue of Cancer Cell.

More information

To learn more about brain and spinal cord cancers visit the American Cancer Society.



-- Madeline Vann



SOURCE: National Cancer Institute, news release, Jan. 7, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Scientists Report Refinements to Brain Surgery
2. Carnegie Mellon study identifies where thoughts of familiar objects occur inside the human brain
3. Language centers revealed, brain surgery refined with new mapping
4. Brain Turns to Positive Thoughts When Faced With Death
5. Brain imaging and genetic studies link thinking patterns to addiction
6. Sleep chemical central to effectiveness of deep brain stimulation
7. Study suggests some brain injuries reduce the likelihood of post-traumatic stress disorder
8. Pharmacyclics Receives Non-Approvable Letter from the FDA for Xcytrin for the Treatment of Lung Cancer Brain Metastases
9. Scientists identify brain abnormalities underlying key element of borderline personality disorder
10. Mental Decline Faster in Brain-Injured Vietnam Vets
11. Regular Walking Protects the Aging Brain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... NJ (PRWEB) , ... December 02, 2016 , ... Sourced ... Water has some unique properties including its unmatched natural purity of just 6 ppm ... clean and crisp. , Nothing Water has been available in several ShopRite and FoodTown ...
(Date:12/2/2016)... ... December 02, 2016 , ... Clarify Health Solutions, Inc., the ... million in an initial round of funding. The round was led by experienced ... can receive far better care through the application of the best technologies from ...
(Date:12/2/2016)... FL (PRWEB) , ... December 02, 2016 , ... ‘Tis ... are winners of $1,000 each from the National Family Partnership and the Drug Enforcement ... families who decorated their homes and the 10 winning schools who decorated their campuses ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... Deloitte Wisconsin 75, an annual ranking and recognition of the largest closely held ... list, having ranked from 2008-2016. In addition, Standard Process was awarded the Talent ...
(Date:11/30/2016)... , ... November 30, 2016 , ... ... tech functions and stylish design wanted by today’s consumers at an affordable price, ... Darin Philip says the new watch is “a game changer” when it comes ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016 Orthopedic Implants (Including Spinal Implants, ... to Gain a Significant Market Share Owing to a Large ... ... According to a new report by Persistence ... Packaging: Clamshell Product Type Segment Projected to Witness a Significantly ...
(Date:12/2/2016)... , Dec. 2, 2016   CytoSorbents Corporation ... commercializing its European Union approved CytoSorb ® cytokine ... surgery patients worldwide, announced that Dr. Phillip Chan ... 9th Annual LD Micro Main Event investor conference ... at the Luxe Sunset Boulevard Hotel in ...
(Date:12/2/2016)... On Thursday, the NASDAQ Composite ended the trading ... edged 0.36% higher, to finish at 19,191.93; and the S&P ... as six out of nine sectors ended the day in ... Services equities: Myriad Genetics Inc. (NASDAQ: MYGN ), ... Inc. (NASDAQ: INCR ), and La Quinta Holdings ...
Breaking Medicine Technology: